BRACHYSTEMIN_I;CYCLO-(PRO-(1)-ALA-(2)-GLY-(3)-PHE-(4)-THR-(5)-THR-(6)-PRO-(7)-TRP-(8))
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 4UKNlGYKLhg |
|---|---|
| InChI | InChI=1S/C43H55N9O10/c1-23-37(56)45-22-34(55)47-30(19-26-11-5-4-6-12-26)38(57)49-35(24(2)53)41(60)50-36(25(3)54)43(62)52-18-10-16-33(52)40(59)48-31(20-27-21-44-29-14-8-7-13-28(27)29)42(61)51-17-9-15-32(51)39(58)46-23/h4-8,11-14,21,23-25,30-33,35-36,44,53-54H,9-10,15-20,22H2,1-3H3,(H,45,56)(H,46,58)(H,47,55)(H,48,59)(H,49,57)(H,50,60)/t23-,24?,25?,30-,31-,32-,33-,35-,36-/m0/s1 |
| InChIKey | KADRLXHCWSLEIB-CERWQYOQSA-N |
| Mol Weight | 858.0 g/mol |
| Molecular Formula | C43H55N9O10 |
| Exact Mass | 857.407189 g/mol |
| Enantiomer InChIKey | KADRLXHCWSLEIB-GRIBADDJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
PHAKELLISTATIN_15;CYCLO-(PRO-(1)-TRP-ILE-PRO-(2)-LEU-(1)-THR-PRO-(3)-LEU-(2))
PHAKELLISTATIN-13
KAWAGUCHIPEPTIN_B
LOLOATIN-C;CYClIC-(L-ASPARAGINYL-L-ASPARTYL-L-TRYPTOPHANE-L-VALYL-L-ORNITHINYL-L-LEUCYL-D-TYROSYL-L-PROLYL-L-TRYPTOPHANE-D-PHENYLALANYL)
LOLOATIN-B;CYClIC-(L-ASPARAGINYL-L-ASPARTYL-L-TRYPTOPHANE-L-VALYL-L-ORNITHINYL-L-LEUCYL-D-TYROSYL-L-PROLYL-L-PHENYLALANYL-D-PHENYLALANYL)
STREPTOCIDIN-D
STREPTOCIDIN-C
CYCLOLINOPEPTIDE-G;CYCLO-(PRO-PHE-PHE-TRP-ILE-MSO-LEU-MSO)
BRACHYSTEMIN_H;CYCLO-(PRO-(1)-PHE-(2)-ILE-(3)-GLY-(4)-ALA-(5)-PRO-(6)-TRP-(7)-ASN-(8))
CYCLOLINOPEPTIDE-H;CYCLO-(PRO-PHE-PHE-TRP-ILE-MSO-LEU-MET)
| Title | Journal or Book | Year |
|---|---|---|
| Bioactive Compounds from the Aerial Parts of Brachystemma calycinum and Structural Revision of an Octacyclopeptide | Journal of Natural Products | 2011 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.